Literature DB >> 20061345

Sulpiride augmentation for schizophrenia.

Jijun Wang1, Ichiro M Omori, Mark Fenton, Bernardo Soares.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20061345      PMCID： PMC2833130          DOI： 10.1093/schbul/sbp163

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.

Authors:  Iris E Sommer; Marieke J H Begemann; Anke Temmerman; Stefan Leucht
Journal:  Schizophr Bull       Date:  2011-03-21       Impact factor: 9.306

2.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

3.  Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children.

Authors:  Huan Gao; Yuan Ni; Xueying Mo; Dantong Li; Shan Teng; Qingsheng Huang; Shuai Huang; Guangjian Liu; Sheng Zhang; Yaping Tang; Long Lu; Huiying Liang
Journal:  Comput Struct Biotechnol J       Date:  2021-07-01       Impact factor: 7.271

4.  Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects.

Authors:  Carla Rognoni; Arianna Bertolani; Claudio Jommi
Journal:  Clin Drug Investig       Date:  2021-03-09       Impact factor: 2.859
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.